Smoking Clinical Trial
Official title:
Implementing Tobacco Control in Dental Practice
Our goal is to test a dentist-hygienist team intervention to help dental patients quit
smoking and determine if it can be effectively and cost-effectively implemented and
sustained.
Staff in half of the HMO's 14 large dental facilities will be trained to provide brief
cessation advice and assistance and to encourage smokers to talk by phone with a tobacco
counselor before they leave the dental office. Phone counselors will provide brief
counseling, assess stage, and offer a full list of cessation services. The Active Referral
intervention strategy is both practical and innovative, as it takes advantage of available
resources; efficiently distributes intervention activities between dentists, hygienists, and
counseling specialists; and could be delivered in individual, small, or large dental
practices. This intervention is provided as part of routine care to all patients seen for
annual dental and periodontal exams.Consented patients will receive a short phone survey
shortly after the exam to assess smoking status, satisfaction with delivery of support
services,and satisfaction with intervention. Consented patients in treatment and control
facilities will be surveyed by phone at one year to re-assess smoking status and
satisfaction with services.
The purpose of this behavioral effectiveness trial is to test the feasibility,
effectiveness, cost-effectiveness, and sustainability of a team approach for delivering
smoking cessation assistance to interested smokers seen within a single well-integrated
group-model dental HMO. We and others have already demonstrated the efficacy of the 5-A
model in medical and hospital clinical settings. The need now is to show that a practical
and innovative team approach with a centralized tobacco quitline component 1) can be
disseminated throughout dental care offices; 2) can be effectively and consistently
delivered by dentists and hygienists; 3)can be maintained over time, and 4) will have a
positive and cost-effective impact on patient smoking-cessation rates.
The HMO's 14 dental care offices will be randomly assigned to usual care or a Assisted
Referral condition. In the Referral condition, dentists and hygienists will be trained to,
as part of routine annual dental exams, assess, advise, and connect interested tobacco users
by phone to a professionally staffed centralized tobacco quitline. If patients prefer,
dental staff will have quitline staff call the patients back at a more convenient time.
Quitline staff will offer brief counseling and assessment and a full menu of cessation
services, including multi-session telephone and face-to-face programs and medications. The
intervention will be provided as a part of routine care to all adult patients receiving
annual general dental or periodontal exams.
Primary and secondary outcome measure. The primary hypothesis is that treatment will
increase the probability of 30-day sustained cessation from all forms of tobacco, as
reported by randomly selected patients one year after the initial clinic visit. Other
secondary follow-up measures will include one-week and 6-month point prevalence at one year,
stage of change, quit attempts during the year, and smoking rate among continuing smokers.
CHR research staff will survey a random sample of 2,800 consenting adult cigarette smokers
in both Referral and Usual Care facilities shortly after their visits to assess rates of
advice and referral, satisfaction, and other process measures. Patients will be sampled
throughout a 15-month period to assess sustainability of the staff's efforts. Consenting
patients will be resurveyed after one year to assess smoking cessation outcomes. Patients
seen by dentists or hygienists who routinely practice in multiple facilities will be
excluded to minimize contamination.
The Kaiser Permanente Dental Care Program (KPDCP) is a well-integrated single-group dental
HMO with a unified administrative structure. KPDCP and the Kaiser Permanente Center for
Health Research (CHR) are both divisions within a single institution— Kaiser Permanente
Northwest. The dental program has 14 clinical facilities in the Vancouver, Washington;
Portland, Oregon; and Salem, Oregon service areas. The dental plan's aim is to implement the
tobacco control program as a permanent change in the routine care that is delivered to all
patients throughout all facilities. In order to evaluate the change process and the impact
of the program, however, they will stagger the rollout of the quality improvement effort
with half of the facilities randomly assigned to begin during phase I and the remainder to
start later once follow-up is complete.
While multiple clinics will offer advice and referral options to smokers, research staff at
only one data collection site (i.e., CHR) will carry out all study recruitment, consent, and
data collection activities as part of the post-visit and annual follow-up surveys. Because
CHR is the only data collection site for study subjects, and the fact that we are all part
of a single well-integrated organization operating under a single IRB, we view this as a
single-site study.
Projected timeline. The first nine months of the project will be devoted to planning,
development and testing the web intervention and final telephone counseling protocol, and
piloting all aspects of the identification, recruitment, assessment, and intervention
components of the study. Recruitment will begin shortly before year 2.
Target population distribution. The target population is 52% women, 15.9% nonwhite or mixed
race, and 7.4% Hispanic.
Data acquisition and entry. Random samples of smoking patients seen for annual general
dental or periodontal exams will be called to complete a short "Current Visit Survey"
shortly after their visits. We will randomly select up to 4,000 smoking patients
(approximately 285 per facility) to contact. We expect to achieve a minimum response rate of
70%, based on a 76% response rate achieved using this same procedure with patients seen for
routine medical visits (Hollis, 2000b). A 70% response rate will yield an estimated 2,800
respondents (200 per facility).
Data analysis. Because clinics rather than patients are the unit of randomization,
adjustments for the intra clinic correlation will be necessary for all treatment
comparisons. The primary outcome analysis is based on the mixed effects logit model: logitY
i:k:l = M +Cl +G k:l +e i:k:l (1)
The adjusted mixed effects logit model will also test for differences between the early and
sustained effects of program implementation on tobacco quit rates by including a
member-level time covariate (T i:k:l) and an interaction term between time and intervention
effect (Cl). A significant interaction term indicates that the early and late intervention
effects differ.
Delivery of the intervention components (e.g., asking, advising, and referring smokers) will
be assessed primarily by analysis of the patient's reports on the post-visit phone survey
they will receive shortly after the visit and the one-year follow-up phone survey. Fields in
the computerized dental record will provide another somewhat limited source of information
on rates of asking, advising, and referring smokers.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02649556 -
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Completed |
NCT03305978 -
Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.
|
N/A | |
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Active, not recruiting |
NCT02752022 -
Monitoring the Transition From Smoking to E-cigarettes
|
||
Completed |
NCT02901171 -
The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation
|
N/A | |
Completed |
NCT02912000 -
TEACH: Technology Evaluation to Address Child Health
|
N/A | |
Completed |
NCT04340830 -
The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02949648 -
Electronic Cigarette Use and Quitting in Youth
|
N/A | |
Completed |
NCT02246114 -
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
|
N/A | |
Completed |
NCT02945371 -
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
|
N/A | |
Completed |
NCT02008292 -
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
|
N/A | |
Completed |
NCT01954407 -
Young Adults' Responses to Anti-smoking Messages
|
N/A | |
Completed |
NCT03448900 -
Intervention Study for Smoking Cessation in Spanish College Students
|
N/A |